Summary
GlobalData's clinical trial report, “Ventricular Fibrillation Global Clinical Trials Review, H2, 2018" provides an overview of Ventricular Fibrillation clinical trials scenario. This report provides top line data relating to the clinical trials on Ventricular Fibrillation. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Companies Mentioned
Gilead Sciences Inc
Baxter International Inc
Sanofi
Ningbo Dahongying Pharmaceutical Co Ltd
Medtronic Plc
Johnson & Johnson
Isala Klinieken
ICON Plc
F. Hoffmann-La Roche Ltd
Anapharm Inc.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Clinical Trials by G7 Countries: Proportion of Ventricular Fibrillation to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Ventricular Fibrillation to Cardiovascular Clinical Trials 19
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Ventricular Fibrillation Therapeutics Clinical Trials 29
Prominent Drugs 31
Clinical Trial Profile Snapshots 32
Appendix 50
Abbreviations 50
Definitions 50
Research Methodology 51
Secondary Research 51
About GlobalData 51
Contact Us 52
Source 52
List of Tables
Ventricular Fibrillation Therapeutics, Global, Clinical Trials by Region, 2018* 7
Ventricular Fibrillation Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Ventricular Fibrillation Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Ventricular Fibrillation Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2018* 11
Ventricular Fibrillation Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Ventricular Fibrillation Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Ventricular Fibrillation Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 14
Proportion of Ventricular Fibrillation to Cardiovascular Clinical Trials, G7 Countries (%), 2018* 16
Ventricular Fibrillation Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
Ventricular Fibrillation Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
Proportion of Ventricular Fibrillation to Cardiovascular Clinical Trials, E7 Countries (%), 2018* 20
Ventricular Fibrillation Therapeutics, Global, Clinical Trials by Phase, 2018* 21
Ventricular Fibrillation Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 22
Ventricular Fibrillation Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23
Ventricular Fibrillation Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24
Ventricular Fibrillation Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25
Ventricular Fibrillation Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 26
Ventricular Fibrillation Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 28
Ventricular Fibrillation Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 30
Ventricular Fibrillation Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 31
List of Figures
Ventricular Fibrillation Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Ventricular Fibrillation Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Ventricular Fibrillation Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Ventricular Fibrillation Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2018* 11
Ventricular Fibrillation Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Ventricular Fibrillation Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
Ventricular Fibrillation Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 14
Proportion of Ventricular Fibrillation to Cardiovascular Clinical Trials, G7 Countries (%), 2018* 15
Ventricular Fibrillation Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
Ventricular Fibrillation Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
Proportion of Ventricular Fibrillation to Cardiovascular Clinical Trials, E7 Countries (%), 2018* 19
Ventricular Fibrillation Therapeutics, Global, Clinical Trials by Phase (%), 2018* 21
Ventricular Fibrillation Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 22
Ventricular Fibrillation Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23
Ventricular Fibrillation Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24
Ventricular Fibrillation Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25
Ventricular Fibrillation Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 26
Ventricular Fibrillation Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 27
Ventricular Fibrillation Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 29
Ventricular Fibrillation Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 31
GlobalData Methodology 51
